Patricio O’Donnell combines an outstanding academic career in Neuroscience with experience in drug discovery and development for neuropsychiatric indications. He is VicePresident and Head of Translational Medicine at Sage Therapeutics. Dr. O’Donnell grew up in Buenos Aires, Argentina and earned his M.D. and Ph.D. degrees from the University of Buenos Aires. Dr. O’Donnell worked as a postdoctoral fellow with Anthony Grace at the University of Pittsburgh, where he pioneered studies on the physiological properties of the nucleus accumbens, and then moved on to establishing his own research program at Albany Medical College. In 2006 he was recruited by the University of Maryland, and in 2013 he moved to Pfizer. In 2017 he joined Takeda Translational Research and Early Clinic group, and in 2022 he moved to his current position at Sage Therapeutics.